NCT00554411已完成不适用
Assessing Changes at the Ocular Surface Following the Switch From Xalatan to Travatan Z.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 22
- 试验地点
- 1
- 主要终点
- Change in Signs and Symptoms of Ocular Surface Disease
研究概览
简要总结
Hypothesis: Changing to Travatan Z therapy increases the tear film break up time of subjects on Xalatan therapy presenting with ocular surface disease.
详细描述
Patients who have been taking Xalatan monotherapy to treat their glaucoma and presenting with ocular surface disease will be advised to switch their medication to Travatan Z. Test results will be recorded at the day that the medication was changed and at follow-up to determine if there is a measurable change in tear film break up, corneal staining and in the Ocular Surface Disease Index.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •on Xalatan monotherapy from 1 to 18 months
- •18 years of age or older
- •has been diagnosed with ocular surface disease
排除标准
- •special populations such as children, pregnant females, prisoners, etc.
结局指标
主要结局
Change in Signs and Symptoms of Ocular Surface Disease
时间窗: 6 months
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®Glaucoma,Open-AngleOcular HypertensionNCT00486252Pfizer's Upjohn has merged with Mylan to form Viatris Inc.996
招募中
Unknown
Changes in ocular surface after instillation of eye drops containing PVPHealthy wearers. It is expected to find ways to reduce contact lens discomfort.JPRN-jRCT1031230239Hori Yuichi26
已完成
不适用
Early Changes Among FLEx, LASIK and FS-LASIKMyopiaAstigmatismNCT02551796Sun Yat-sen University75
已完成
4 期
Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy VolunteersGlaucomaNCT00468988Alcon Research30
Unknown
不适用
Tear Film Evaluation After PhacoemulsificationCortical Senile CataractNCT02238015Zheng Qian60